✦ LIBER ✦

Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report

✍ Scribed by A. Hourvitz; R. Mosseri; A. Solomon; Y. Yehezkelli; J. Atsmon; Y. L. Danon; R. Koren; D. Shouval

Book ID: 115076172
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 577 KB
Volume: 3
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.1996.tb00079.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety in newborns of

Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens

✍ J.C. Soulié; P. Devillier; J. Santarelli; A. Goudeau; P. Vermeulen; M. Guellier; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Comparative safety and immunogenicity of

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens

✍ Emil Miskovsky; Kenneth Gershman; Mary Lou Clements; Thomas Cupps; G. Calandra; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 544 KB

Recombinant DNA hepatitis B vaccine cont

Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity

✍ I. Yap; R. Guan; S.H. Chan 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Safety and immunogenicity of a novel mam

Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children

✍ Raul Raz; Ron Dagan; Aharon Gallil; Gerta Brill; Imad Kassis; Ronit Koren 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Immunogenicity of a recombinant pre-S2-c

Immunogenicity of a recombinant pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster

✍ B. Bucher; P. Francioli; B. Geudelin; B. Fritzell; D. Lavanchy; P. C. Frei 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 660 KB

Safety and immunogenicity of a recombina

Safety and immunogenicity of a recombinant hepatitis B vaccine

✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.